Authors' Response to the Letter by Lamarca et al. Entitled "temozolomide-Capecitabine Chemotherapy for Neuroendocrine Neoplasms: The Dilemma of Treatment Duration" Regarding "activity and Safety of Standard and Prolonged Capecitabine/Temozolomide Administration in Patients with Advanced Neuroendocrine Neoplasms"

Eleftherios Chatzellis; Kosmas Daskalakis; Anna Angelousi; Marina Tsoli; Krystallenia I. Alexandraki; Ewa Wachula; Amichay Meirovitz; Ofra Maimon; Simona Grozinsky-Glasberg; David Gross; Beata Kos-Kudła; Anna Koumarianou; Gregory Kaltsas

doi:10.1159/000503999

Authors' Response to the Letter by Lamarca et al. Entitled "temozolomide-Capecitabine Chemotherapy for Neuroendocrine Neoplasms: The Dilemma of Treatment Duration" Regarding "activity and Safety of Standard and Prolonged Capecitabine/Temozolomide Administration in Patients with Advanced Neuroendocrine Neoplasms"

Eleftherios Chatzellis
, Kosmas Daskalakis
, Anna Angelousi
, Marina Tsoli
, Krystallenia I. Alexandraki
, Ewa Wachula
, Amichay Meirovitz
, Ofra Maimon
, Simona Grozinsky-Glasberg
, David Gross
, Beata Kos-Kudła
, Anna Koumarianou
, Gregory Kaltsas

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English
Pages (from-to)	158-160
Number of pages	3
Journal	Neuroendocrinology
Volume	110
Issue number	1-2
DOIs	https://doi.org/10.1159/000503999
State	Published - 1 Jan 2020
Externally published	Yes

ASJC Scopus subject areas

Endocrinology, Diabetes and Metabolism
Endocrinology
Endocrine and Autonomic Systems
Cellular and Molecular Neuroscience

Access to Document

10.1159/000503999

Cite this

Chatzellis, E., Daskalakis, K., Angelousi, A., Tsoli, M., Alexandraki, K. I., Wachula, E., Meirovitz, A., Maimon, O., Grozinsky-Glasberg, S., Gross, D., Kos-Kudła, B., Koumarianou, A., & Kaltsas, G. (2020). Authors' Response to the Letter by Lamarca et al. Entitled "temozolomide-Capecitabine Chemotherapy for Neuroendocrine Neoplasms: The Dilemma of Treatment Duration" Regarding "activity and Safety of Standard and Prolonged Capecitabine/Temozolomide Administration in Patients with Advanced Neuroendocrine Neoplasms". Neuroendocrinology, 110(1-2), 158-160. https://doi.org/10.1159/000503999

Chatzellis, Eleftherios ; Daskalakis, Kosmas ; Angelousi, Anna et al. / Authors' Response to the Letter by Lamarca et al. Entitled "temozolomide-Capecitabine Chemotherapy for Neuroendocrine Neoplasms : The Dilemma of Treatment Duration" Regarding "activity and Safety of Standard and Prolonged Capecitabine/Temozolomide Administration in Patients with Advanced Neuroendocrine Neoplasms". In: Neuroendocrinology. 2020 ; Vol. 110, No. 1-2. pp. 158-160.

@article{5ffa3a1abeef48c1a11cb314ce07c4c2,

title = "Authors' Response to the Letter by Lamarca et al. Entitled {"}temozolomide-Capecitabine Chemotherapy for Neuroendocrine Neoplasms: The Dilemma of Treatment Duration{"} Regarding {"}activity and Safety of Standard and Prolonged Capecitabine/Temozolomide Administration in Patients with Advanced Neuroendocrine Neoplasms{"}",

author = "Eleftherios Chatzellis and Kosmas Daskalakis and Anna Angelousi and Marina Tsoli and Alexandraki, \{Krystallenia I.\} and Ewa Wachula and Amichay Meirovitz and Ofra Maimon and Simona Grozinsky-Glasberg and David Gross and Beata Kos-Kud{\l}a and Anna Koumarianou and Gregory Kaltsas",

year = "2020",

month = jan,

day = "1",

doi = "10.1159/000503999",

language = "English",

volume = "110",

pages = "158--160",

journal = "Neuroendocrinology",

issn = "0028-3835",

publisher = "S. Karger AG",

number = "1-2",

}

Chatzellis, E, Daskalakis, K, Angelousi, A, Tsoli, M, Alexandraki, KI, Wachula, E, Meirovitz, A, Maimon, O, Grozinsky-Glasberg, S, Gross, D, Kos-Kudła, B, Koumarianou, A & Kaltsas, G 2020, 'Authors' Response to the Letter by Lamarca et al. Entitled "temozolomide-Capecitabine Chemotherapy for Neuroendocrine Neoplasms: The Dilemma of Treatment Duration" Regarding "activity and Safety of Standard and Prolonged Capecitabine/Temozolomide Administration in Patients with Advanced Neuroendocrine Neoplasms"', Neuroendocrinology, vol. 110, no. 1-2, pp. 158-160. https://doi.org/10.1159/000503999

Authors' Response to the Letter by Lamarca et al. Entitled "temozolomide-Capecitabine Chemotherapy for Neuroendocrine Neoplasms: The Dilemma of Treatment Duration" Regarding "activity and Safety of Standard and Prolonged Capecitabine/Temozolomide Administration in Patients with Advanced Neuroendocrine Neoplasms". / Chatzellis, Eleftherios; Daskalakis, Kosmas; Angelousi, Anna et al.
In: Neuroendocrinology, Vol. 110, No. 1-2, 01.01.2020, p. 158-160.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Authors' Response to the Letter by Lamarca et al. Entitled "temozolomide-Capecitabine Chemotherapy for Neuroendocrine Neoplasms

T2 - The Dilemma of Treatment Duration" Regarding "activity and Safety of Standard and Prolonged Capecitabine/Temozolomide Administration in Patients with Advanced Neuroendocrine Neoplasms"

AU - Chatzellis, Eleftherios

AU - Daskalakis, Kosmas

AU - Angelousi, Anna

AU - Tsoli, Marina

AU - Alexandraki, Krystallenia I.

AU - Wachula, Ewa

AU - Meirovitz, Amichay

AU - Maimon, Ofra

AU - Grozinsky-Glasberg, Simona

AU - Gross, David

AU - Kos-Kudła, Beata

AU - Koumarianou, Anna

AU - Kaltsas, Gregory

PY - 2020/1/1

Y1 - 2020/1/1

UR - https://www.scopus.com/pages/publications/85077761506

U2 - 10.1159/000503999

DO - 10.1159/000503999

M3 - Letter

C2 - 31597137

AN - SCOPUS:85077761506

SN - 0028-3835

VL - 110

SP - 158

EP - 160

JO - Neuroendocrinology

JF - Neuroendocrinology

IS - 1-2

ER -

Chatzellis E, Daskalakis K, Angelousi A, Tsoli M, Alexandraki KI, Wachula E et al. Authors' Response to the Letter by Lamarca et al. Entitled "temozolomide-Capecitabine Chemotherapy for Neuroendocrine Neoplasms: The Dilemma of Treatment Duration" Regarding "activity and Safety of Standard and Prolonged Capecitabine/Temozolomide Administration in Patients with Advanced Neuroendocrine Neoplasms". Neuroendocrinology. 2020 Jan 1;110(1-2):158-160. doi: 10.1159/000503999

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this